Role of daratumumab in relapsed or refractory multiple myeloma patient: A meta-analysis and literature to review

Role of daratumumab in relapsed or refractory multiple myeloma patient: A meta-analysis and literature to review

Introduction: With an increase in number of cases of relapsed or refractory multiple myeloma (RRMM), scientist have discovered various combination of medications among which one is daratumumab, Daratumumab is a mono-clonal antibody which attacks CD-38 markers present in abundance on the surface of m...

Full description

Bibliographic Details
Main Authors: Abubakar Tauseef, Maryam Zafar, Peter Silberstein, Joseph Nahas, Thomas Frederickson, Faith Abodunrin, Anum Abbas, Wafa Arshad, Noman Lateef, Hussain Rangoonwala, Sara Albagoush, Mohsin Mirza
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Journal of Family Medicine and Primary Care
Subjects:
daratumumab
literature
multiple myeloma
refractory
relapsed
role
Online Access:http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=6;spage=2648;epage=2655;aulast=Tauseef

Internet

http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=6;spage=2648;epage=2655;aulast=Tauseef

Similar Items